Role of CHK2 in cancer development

被引：30

作者：

Perona, Rosario ^{[1
,2
]}

Moncho-Amor, Veronica ^{[1
,2
]}

Machado-Pinilla, Rosario ^{[1
,2
]}

Belda-Iniesta, Cristobal ^{[3
]}

Sanchez Perez, Isabel ^{[1
,2
]}

机构：

[1] Univ Autonoma Madrid, CSIC, Inst Invest Biomed, ES-28029 Madrid, Spain

[2] UAM, CSIC, CIBERER, Translat Oncol Unit, Valencia, Spain

[3] Univ Autonoma Madrid, Univ Hosp La Paz, Div Med Oncol, CSIC,Translat Oncol Unit, ES-28029 Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2008年 / 10卷 / 09期

关键词：

CHK2; ATM; ATR; DNA damage; checkpoints; chemotherapy;

D O I：

10.1007/s12094-008-0248-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DNA repair pathways enable tumour cells to survive DNA damage induced by external agents such as therapeutic treatments. Signalling cascades involved in these pathways comprise the DNA-dependent protein kinase (DNA-PK), Ataxia-telangiectasia mutated (ATM), ATM and Rad3 related (ATR) and checkpoint kinases I and 2 (Chk1/Chk2), among others. ATM and ATR phosphorylate, respectively, Chk2 and Chk1, leading to activation of checkpoints. Chk2 acts as a signal distributor, dispersing checkpoint signal to downstream targets such as p53, Cdc25A, Cdc25C, BRCA1 and E2F1. A role of Chk2 as a candidate tumour suppressor has been suggested based on both mouse genetics and somatic tumour studies. We will discuss here the possible role of this kinase in human carcinogenesis and the possibility to use it as a target to increment DNA damage in cancer cells in response to DNA-damaging therapies.

引用

页码：538 / 542

页数：5

共 50 条

[21] Chk2 mediates RITA-induced apoptosis [J].

de Lange, J. ;

Verlaan-de Vries, M. ;

Teunisse, A. F. A. S. ;

Jochemsen, A. G. .

CELL DEATH AND DIFFERENTIATION, 2012, 19 (06) :980-989

[22] Identification of novel, selective and potent Chk2 inhibitors [J].

Larson, Gary ;

Yan, Shunqi ;

Chen, Huanming ;

Rong, Frank ;

Hong, Zhi ;

Wu, Jim Zhen .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) :172-175

[23] Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks [J].

Buscemi, G ;

Perego, P ;

Carenini, N ;

Nakanishi, M ;

Chessa, L ;

Chen, JJ ;

Khanna, K ;

Delia, D .

ONCOGENE, 2004, 23 (46) :7691-7700

[24] Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks [J].

Giacomo Buscemi ;

Paola Perego ;

Nives Carenini ;

Makoto Nakanishi ;

Luciana Chessa ;

Junjie Chen ;

KumKum Khanna ;

Domenico Delia .

Oncogene, 2004, 23 :7691-7700

[25] Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo [J].

Niida, Hiroyuki ;

Murata, Kazuhiro ;

Shimada, Midori ;

Ogawa, Kumiko ;

Ohta, Kumiko ;

Suzuki, Kyoko ;

Fujigaki, Hidetsugu ;

Khaw, Aik Kia ;

Banerjee, Birendranath ;

Hande, M. Prakash ;

Miyamoto, Tomomi ;

Miyoshi, Ichiro ;

Shirai, Tomoyuki ;

Motoyama, Noboru ;

Delhase, Mireille ;

Appella, Ettore ;

Nakanishi, Makoto .

EMBO JOURNAL, 2010, 29 (20) :3558-3570

[26] AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival [J].

Ta, Huy Q. ;

Dworak, Natalia ;

Ivey, Melissa L. ;

Roller, Devin G. ;

Gioeli, Daniel .

ELIFE, 2020, 9 :1-19

[27] EAPP modulates the activity of p21 and Chk2 [J].

Andorfer, Peter ;

Schwarzmayr, Ludwig ;

Rotheneder, Hans .

CELL CYCLE, 2011, 10 (13) :2077-2082

[28] Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response [J].

Stracker, Travis H. ;

Usui, Takehiko ;

Petrini, John H. J. .

DNA REPAIR, 2009, 8 (09) :1047-1054

[29] Polo-like kinase 4 phosphorylates Chk2 [J].

Petrinac, Steve ;

Ganuelas, Melissa L. ;

Bonni, Sepal ;

Nantais, Jordan ;

Hudson, John W. .

CELL CYCLE, 2009, 8 (02) :327-329

[30] Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites [J].

S G Durkin ;

M F Arlt ;

N G Howlett ;

T W Glover .

Oncogene, 2006, 25 :4381-4388

← 1 2 3 4 5 →